Darzalex Faspro’s approval for smoldering multiple myeloma could allow for earlier intervention and reduce the risk of ...
The FDA previously placed two clinical studies on hold, including the Phase III trial in which the liver toxicity occurred.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback